1. Home
  2. UDMY vs ABCL Comparison

UDMY vs ABCL Comparison

Compare UDMY & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Udemy Inc.

UDMY

Udemy Inc.

HOLD

Current Price

$5.24

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.21

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UDMY
ABCL
Founded
2009
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
UDMY
ABCL
Price
$5.24
$4.21
Analyst Decision
Buy
Buy
Analyst Count
10
5
Target Price
$9.00
$7.75
AVG Volume (30 Days)
4.3M
4.2M
Earning Date
02-05-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$795,801,000.00
$35,325,000.00
Revenue This Year
$2.34
$25.45
Revenue Next Year
$2.66
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
2.53
7.17
52 Week Low
$4.86
$1.89
52 Week High
$10.61
$6.52

Technical Indicators

Market Signals
Indicator
UDMY
ABCL
Relative Strength Index (RSI) 39.33 58.74
Support Level $5.03 $4.08
Resistance Level $5.95 $4.66
Average True Range (ATR) 0.25 0.26
MACD -0.08 0.09
Stochastic Oscillator 16.42 64.77

Price Performance

Historical Comparison
UDMY
ABCL

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: